tiprankstipranks

Michel Detheux Insider Profile

4 Followers
Michel Detheux, CEO at iTeos Therapeutics, holds 58.90K shares in iTeos Therapeutics (Ticker: ITOS).
tipranks
Michel Detheux

Michel Detheux
iTeos Therapeutics (ITOS)
CEO

Not Ranked
Michel Detheux has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$633K
100.00%
A breakdown of Michel Detheux's holdings

Insider Roles

iTeos Therapeutics
(ITOS)
CEO
Roles that Michel Detheux holds in companies

Most Profitable Insider Trade

Stock:
iTeos Therapeutics
(ITOS)
Rating:Informative Sell
Date:Apr 19, 2022 - Apr 19, 2023
Return:+55.30%
The most profitable trade made by Michel Detheux

Michel Detheux's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
iTeos Therapeutics
Dec 07, 2023
CEO
Uninformative Buy
$632.62K
Success Rate for
ITOS
1 out of 1 profitable transactions on
ITOS
100%
Average Return for
ITOS
Average return per transaction on
ITOS
+55.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 14, 2022
Uninformative Buy
$0.00
-
$0.00
Dec 07, 2023
Uninformative Buy
$0.00
-
$0.00
Jun 16, 2021
Uninformative Sell
$826.48K
-
$28.49
Aug 25, 2021
Uninformative Sell
$240.89K
-
$28.05
Aug 31, 2021
Uninformative Sell
$412.48K
-
$28.13
List of latest transactions for each holding click on a transaction to see Michel Detheux's performance on stock

Michel Detheux insider profile FAQ

What is the percentage of profitable transactions made by Michel Detheux?
The percentage of profitable transactions made by Michel Detheux is ―.
    What is the average return per transaction made by Michel Detheux?
    The average return per transaction made by Michel Detheux is ―.
      What stocks does Michel Detheux hold?
      Michel Detheux holds: ITOS stocks.
        What was Michel Detheux’s latest transaction?
        Michel Detheux latest transaction was an Uninformative Buy of ―.
          What was Michel Detheux's most profitable transaction?
          Michel Detheux’s most profitable transaction was an Informative Sell of ITOS stock on April 19, 2022. The return on the trade was 55.30%.
            What is Michel Detheux's role in iTeos Therapeutics?
            Michel Detheux's role in iTeos Therapeutics is CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.